Company profile: Phlow
1.1 - Company Overview
Company description
- Provider of affordable, quality essential medicines using U.S.-based advanced manufacturing processes. Helps ensure the quality, safety, and affordability of pharmaceutical products of strategic importance to the United States, leveraging advanced manufacturing platforms, including continuous manufacturing.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Phlow
Leukocare
HQ: Germany
Website
- Description: Provider of biopharmaceutical formulation development services operating at the interface of drug substance and drug product, combining bioinformatics, artificial intelligence and data science. Offerings include drug substance characterization, developability assessment, particle characterization, stability studies, and in silico analytics to optimize and accelerate development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Leukocare company profile →
Molecular Medicine
HQ: United States
Website
- Description: Provider of process R&D, process and assay development, clinical manufacturing, fill/finish, and GMP storage services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Molecular Medicine company profile →
eStudySite
HQ: United States
Website
- Description: Provider of clinical research services delivering study-related care and conducting inpatient and outpatient protocols, including first-in-human, pivotal, and post-marketing studies; specializing in infectious disease trials (antibiotics, antivirals, vaccines, diagnostics). Expertise in endocrinology, hepatology, dermatology, gastroenterology; infusion center; community recruitment; ICH/FDA/GCP-compliant, ACLS/BLS-certified staff.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full eStudySite company profile →
North Georgia Clinical Research
HQ: United States
Website
- Description: Provider of FDA-approved clinical trials evaluating new treatments and medications for various health conditions, conducted at its Woodstock, GA facility. Studies include an Alzheimer's prevention study, cardiovascular and diabetes trials, elevated lipoprotein(a) research, and a high cholesterol study testing an oral investigational drug to lower LDL-C and reduce cardiovascular risk.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full North Georgia Clinical Research company profile →
Metrion Biosciences
HQ: United Kingdom
Website
- Description: Provider of specialist ion channel contract research for drug discovery to pharmaceutical and bioscience customers worldwide, including validated ion channel screening, CiPA-compliant human cardiac ion channel assays (GLP hERG), neuroscience ion channel and neurotoxicology screening, translational phenotypic assays, integrated ion channel research programs, and HTS for hit finding, lead optimization, and selectivity profiling.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Metrion Biosciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Phlow
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Phlow
2.2 - Growth funds investing in similar companies to Phlow
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Phlow
4.2 - Public trading comparable groups for Phlow
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →